Joseph P. Lucia & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Joseph P. Lucia & Associates's PFE Position: Q2 2026 in Review
Joseph P. Lucia & Associates increased its Pfizer (PFE) stake by 0.08% in Q2 2026, buying an estimated $183 and bringing the position to 8,608 shares worth $207K. The position accounts for 0.06% of the portfolio, ranked #180.
Joseph P. Lucia & Associates first reported a position in PFE in Q1 2019 and has held it in 22 quarters since. The position peaked at $901K in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Joseph P. Lucia & Associates held 8,608 shares of Pfizer worth $207K as of Q2 2026.
- Joseph P. Lucia & Associates bought 7 Pfizer shares in Q2 2026, an estimated $183.
- Pfizer made up 0.06% of Joseph P. Lucia & Associates's portfolio in Q2 2026, its #180 holding.
- Joseph P. Lucia & Associates first reported a position in Pfizer in Q1 2019 and has held it in 22 quarters since.
- Joseph P. Lucia & Associates's Pfizer position peaked at $901K in Q3 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Joseph P. Lucia & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.